Jakob R Passweg

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. ncbi Immunosuppressive therapy for patients with myelodysplastic syndrome: a prospective randomized multicenter phase III trial comparing antithymocyte globulin plus cyclosporine with best supportive care--SAKK 33/99
    Jakob R Passweg
    Medecin Chef de Service, Service d Hematologie, Departement Medecine Interne, Hopitaux Universitaires de Geneve, Rue Micheli du Crest 24, 1211 Geneva 14, Switzerland
    J Clin Oncol 29:303-9. 2011
  2. ncbi No evidence of plasticity in hair follicles of recipients after allogeneic hematopoietic stem cell transplantation
    Alicia Rovo
    Division of Hematology, University Hospital Basel, Basel, Switzerland
    Exp Hematol 33:909-11. 2005
  3. ncbi Natural-killer-cell-based treatment in haematopoietic stem-cell transplantation
    Jakob R Passweg
    Service d Hematologie, Departement Medecine Interne, Hopitaux Universitaires de Geneve, Geneve, Switzerland
    Best Pract Res Clin Haematol 19:811-24. 2006

Detail Information

Publications3

  1. ncbi Immunosuppressive therapy for patients with myelodysplastic syndrome: a prospective randomized multicenter phase III trial comparing antithymocyte globulin plus cyclosporine with best supportive care--SAKK 33/99
    Jakob R Passweg
    Medecin Chef de Service, Service d Hematologie, Departement Medecine Interne, Hopitaux Universitaires de Geneve, Rue Micheli du Crest 24, 1211 Geneva 14, Switzerland
    J Clin Oncol 29:303-9. 2011
    ..Combined antithymocyte globulin (ATG) and cyclosporine (CSA) is most effective in patients with immune-mediated marrow failure...
  2. ncbi No evidence of plasticity in hair follicles of recipients after allogeneic hematopoietic stem cell transplantation
    Alicia Rovo
    Division of Hematology, University Hospital Basel, Basel, Switzerland
    Exp Hematol 33:909-11. 2005
    ..Our data indicate that unmanipulated hematopoietic donor stem cells do not contribute directly to reconstitution even in an organ at highest need for repair...
  3. ncbi Natural-killer-cell-based treatment in haematopoietic stem-cell transplantation
    Jakob R Passweg
    Service d Hematologie, Departement Medecine Interne, Hopitaux Universitaires de Geneve, Geneve, Switzerland
    Best Pract Res Clin Haematol 19:811-24. 2006
    ..Further study is required to determine whether such infusions will be useful in preventing graft rejection, exerting graft-versus-leukaemia effects, and/or hastening immune recovery...